Olmedo, ME;
Forster, M;
Moreno, V;
Lopez-Criado, MP;
Brana, I;
Flynn, M;
Doger, B;
... Calvo, E; + view all
(2021)
Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer. Results from an expansion cohort of a phase I study.
Investigational New Drugs
10.1007/s10637-020-01025-x.
(In press).
Preview |
Text
Olmedo2021_Article_EfficacyAndSafetyOfLurbinected.pdf - Published Version Download (339kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer. Results from an expansion cohort of a phase I study |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1007/s10637-020-01025-x |
| Publisher version: | https://doi.org/10.1007/s10637-020-01025-x |
| Language: | English |
| Additional information: | © 2021 Springer Nature Switzerland AG. This article is licensed under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). |
| Keywords: | Lurbinectedin, PM01183, Small cell lung cancer, Phase I study |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10126758 |
Archive Staff Only
 |
View Item |
